Data-Driven Insights

December 2, 2015   |   Josh Halpern

Renewed Emphasis on Driving the Retail Pharmacy Channel

You might have noticed that we recently announced the release of a new set of channel visualizations focused on the retail pharmacy. In an era when specialty pharmacy so dominates our industry’s headlines, you might be surprised to learn that a growing number of our customers are turning renewed attention and resources to the retail pharmacy channel.  Manufacturers are examining retail pharmacy design and pharmacist engagement with a fresh eye, and some are finding attractive opportunities to improve the patient experience and maximize brand success. First a little history. Back in the 20th century, before the advent of script data, drug […]

Read More

Tags: , ,


October 27, 2015   |   Kevin Leininger

IntegriChain Launches New Hybrid Cloud

We have partnered with Amazon Web Services (AWS) and have big plans to leverage the fastest growing cloud platform on the planet. The rate of growth and innovation in AWS is truly astonishing. I have been in the software business for 25 years and never seen anything quite like it.

Read More


July 13, 2015   |   Digesh Kapadia

An Itch to Ditch our Co-Lo and Move to the Amazon Web Services (AWS) Platform

This was my second year in a row that I attended the AWS Summit in NYC at Jacob Javits. The event coincided with the celebration of 80th birthday of his Holiness the 14th Dalai Lama at the same place, so in some aspect it was a blessed summit. Just like last year, keynote Dr. Werner Vogels, Amazon’s Chief Technology Officer (CTO), touched upon new services they are rolling out, from Elastic File Storage (EFS) to AWS Device Farm and developer tools including AWS CodeCommit, CodePipeline, CodeDeploy, and more. The pace of innovation that happens within Amazon goes to the core of empowerment […]

Read More

Tags: ,


July 9, 2015   |   Dave Weiss

GAO 340B Report: The Debate on Whether 340B Financial Incentives Create “Big Hospitals”

For those of us who monitor the 340B Drug Pricing Program, a fascinating report and industry debate erupted this week over the June 2015 US Government Accountability Office (GAO) Report to Congress entitled “Medicare Part B Drugs: Action Needed to Reduce Financial Incentives to Prescribe 340B Drugs at Participating Hospitals." Debate has broken out after the report showed that while charitable and unreimbursed care are in fact higher at 340B hospitals, especially at those with higher Disproportionate Share Hospital (DSH) adjustments, some notable facts and trends in the program have emerged.

Read More

Tags: , ,



May 21, 2015   |   Sunay Shah

Channel Collaboration Series: Making Pharma Trade Agreement Management Collaborative

Manufacturers and their trade partners work closely to define the parameters and metrics they will measure to ensure maximum value is extracted from the channel when they structure their pay-for-performance contracts. The metrics that are selected and how they are measured vary greatly between manufacturers as there is little evidence of what metrics drive value extraction from the channel.

Read More

Tags: , ,


May 20, 2015   |   Kevin Leininger

Insights from CBI’s Customized Distribution and Pharmacy Strategies Summit

I gave an interesting presentation to a group of pharmacy distribution experts at the recent CBI Customized distribution and Pharmacy Strategies Summit and would like to share some of my insights from the conference. The retail channel is undergoing a significant change and must be thought of and managed differently than in the past. The retail channel is saturated with product and it is getting harder and harder to get product on shelves. It is getting harder and harder to have the right amount of product available for purchase: too little and you risk therapeutic interchange and too much and […]

Read More

Tags: , ,


May 14, 2015   |   Tisha Agarwal

Reality Check for Product Launch: How IntegriChain Can Add Value

There is significant work to be done pre-launch: from defining the market, creating a vision for the brand, identifying leverage points, prioritizing stakeholders, and segmenting the market to creating a value proposition for the brand, creating positioning, messaging, and a go-to-market model, and identifying metrics that will track whether the launch was successful. There is tremendous pressure to get it right and maximize the launch.

Read More

Tags: ,




adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand